Brief: ALX Oncology Q2 Basic EPS USD -0.13
06/08/2026 13:01
BRIEF-ALX Oncology Q2 Basic EPS USD -0.13 Aug 06 (Reuters) - ALX Oncology Q2 income from operations USD -18.033 million.
- Q2 operating expenses USD 18.033 million
- Q2 net income USD -17.971 million
- Q2 EPS USD -0.13
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing